CD274 and non-small cell lung carcinoma: Clinical validation for this axis comes from the work of Katakura et al., who demonstrated a significant inverse correlation between miR-200b and PD-L1 tumor proportion score (TPS) in both tumor cells and serum-derived exosomes from NSCLC patients.